Australia markets open in 2 hours 4 minutes

Medibio Limited (MEB.XA)

CXA - CXA Real-time price. Currency in AUD
Add to watchlist
0.00100.0000 (0.00%)
At close: 11:06AM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3N/A
S&P500 52-week change 3-16.03%
52-week high 30.0010
52-week low 30.0010
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 82.45B
% held by insiders 111.03%
% held by institutions 16.50%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-265.00%

Management effectiveness

Return on assets (ttm)-12.91%
Return on equity (ttm)-108.12%

Income statement

Revenue (ttm)1.01M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-87.90%
Gross profit (ttm)1.01M
EBITDA -2.22M
Net income avi to common (ttm)-12.72M
Diluted EPS (ttm)-0.0010
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.03M
Total cash per share (mrq)0
Total debt (mrq)66.42k
Total debt/equity (mrq)0.94
Current ratio (mrq)0.87
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-1.66M
Levered free cash flow (ttm)-3.77M